论文部分内容阅读
本文通过观察曲美他嗪治疗冠心病合并肺心病与冠心病不伴肺心病,各组20例的疗效对照以了解在伴有肺心病的冠心病患者应用该药时是否更有益。资料与方法一、一般资料:冠状动脉造影证实有冠心病或有明确心肌梗死病史且运动实验阳性150例中选出伴有肺心病的20例为A组,其中男性15例、女性5例,年龄48～68岁。有高血压病10例,血脂异常7例,吸烟3例,冠脉病变为单支、血管狭窄程度60%～70%16例,陈旧性心肌梗死4例;不伴肺心病的冠心病20例为 B 组,其中男性15例、女性5例,年龄48～69岁。有高血压病10例,血脂异常7例,吸烟3例,冠脉病变为单支、血管狭窄程度60～70%者16例,陈旧性心肌梗死
This article through the observation of trimetazidine treatment of coronary heart disease with cor pulmonale and cor pulmonale without cor pulmonale, curative effect of 20 cases in each group control to understand whether the use of the drug in coronary heart disease patients with pulmonary heart disease is more beneficial. Materials and Methods First, the general information: Coronary angiography confirmed a history of coronary heart disease or a clear history of myocardial infarction and exercise test positive in 150 cases were selected with pulmonary heart disease in 20 cases for the A group, including 15 males and 5 females, Age 48 to 68 years old. There were 10 cases of hypertension, 7 cases of dyslipidemia, 3 cases of smoking, coronary artery disease was single, 16 cases of vascular stenosis 60% ~ 70%, 4 cases of old myocardial infarction; coronary heart disease without pulmonary heart disease in 20 cases For the B group, including 15 males and 5 females, aged 48 to 69 years. There were 10 cases of hypertension, 7 cases of dyslipidemia, 3 cases of smoking, coronary artery disease was a single, vascular stenosis of 60 to 70% in 16 cases, old myocardial infarction